Skip to main content
Premium Trial:

Request an Annual Quote

PNNL Wins $10M NIH Grant -- Largest in Lab s History

NEW YORK, Oct. 9 (GenomeWeb) - The National Institutes of Health has awarded Pacific Northwest National Laboratory $10.2 million to support a center for basic research in proteomics -- the largest grant in the government lab's history, the PNNL said today.

The five-year grant designates PNNL an NIH research resource center, and will establish PNNL as a base for proteomics research worldwide. The grant will also fund the development of "advanced instrumentation" for studying proteomics.

"The award will enable PNNL staff to collaborate on important biomedical projects with top NIH-supported researchers," Dick Smith, a Battelle Fellow at PNNL, and director of the resource center housed at the William R. Wiley Environmental Molecular Sciences Laboratory, said in a statement.

Specifically, the grant will help PNNL develop faster proteomics technologies, and will enable researchers there to "increase the speed and sensitivity of proteome measurements, with the aim of allowing studies of the proteins in even a single cell," PNNL said.

The grant also will support improved computational and bioinformatics tools "for extracting and visualizing and ultimately understanding" the center's proteomic data, the PNNL said.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.